Main > ONCOLOGY (**) > Ovarian Cancer MET HRD+ > TREAT.: > UK. A. Olaparib Tab.+BevacizuMAb > Companion Diagnostics>

---

Companion Diagnostics>'s subsections
>(*) USA Approval Date: 2020. 05.11
>Company
>Patent>Assignee; Claims; No.; Etc.
>Patent>Total USA No.: 2
>Patent>UpDate: 2020. 09.15.
>TradeMark
>TradeMark Web-Site

Companion Diagnostics>'s products
This section has no products